Joint pain relief for weekend warriors? new study tests collavant n2
NCT ID NCT07561203
First seen May 05, 2026 · Last updated May 08, 2026 · Updated 1 time
Summary
This study tests whether a daily 40 mg dose of Collavant n2 can reduce knee discomfort in healthy, active men aged 40-65 who run regularly. Eighty amateur male runners with exercise-induced knee pain will be randomly assigned to receive either the supplement or a placebo for a set period. The main goal is to see if the supplement improves joint function and lessens pain after physical activity.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT MALE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Universidad Politecnica de Madrid
Madrid, Madrid, 28040, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.